ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
18
views
0
references
Top references
cited by
10
Cite as...
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
1,962
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
Identification of the critical attribute(s) of EBV gp350 antigen required for elicitation of a neutralizing antibody response in vivo
Author(s):
Bodrey W Ro
,
Corinne Cayatte
,
Lorraine Gemmell
,
Chris Barton
,
Eileen Rao
,
Rui Lin
,
Fengrong Zuo
,
Jennifer Woo
,
Gregory Hayes
,
Esteban Servat
Publication date:
2015-11-01
Journal:
Vaccine
Publisher:
Elsevier BV
Read this article at
ScienceOpen
Publisher
Cite as...
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Malaria vaccine development
Author and article information
Journal
DOI::
10.1016/j.vaccine.2015.10.024
License:
https://www.elsevier.com/tdm/userlicense/1.0/
Data availability:
Comments
Comment on this article
Sign in to comment
scite_
Similar content
1,962
Inhibition of Epstein-Barr virus (EBV) release from P3HR-1 and B95-8 cell lines by monoclonal antibodies to EBV membrane antigen gp350/220.
Authors:
Huy V Q Nguyen
,
Ian Humphreys
,
Maria Medveczky
…
A chimeric EBV gp350/220-based VLP replicates the virion B-cell attachment mechanism and elicits long-lasting neutralizing antibodies in mice
Authors:
Javier Gordon Ogembo
,
Matthew Muraswki
,
Lori McGinnes
…
Differences in the Epstein-Barr Virus gp350 IgA Antibody Response Are Associated With Increased Risk for Coinfection With a Second Strain of Epstein-Barr Virus
Authors:
See all similar
Cited by
10
Vaccination against the Epstein–Barr virus
Authors:
Julia Rühl
,
Carol S. K. Leung
,
Christian Münz
The promise of a prophylactic Epstein–Barr virus vaccine
Authors:
Henry Balfour
,
David O. Schmeling
,
Jennifer Grimm-Geris
The Status and Prospects of Epstein–Barr Virus Prophylactic Vaccine Development
Authors:
Cong Sun
,
Xin-chun Chen
,
Yin-feng Kang
…
See all cited by
Version 1
Version 1